FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

FONAR CorporationNASDAQ: FONR

Income Tax Expense · Q3 FY2026 · quarter ended Mar 2026

Income tax expense declines year over year

Q3 FY2026 income tax expense of $492K fell 51.1% year over year, behind the -24.4% change in trailing-twelve-month income tax expense. Sequentially, it fell 45.5% from the prior quarter. Over 3 fiscal years it compounded at -17.5% a year.

Context

  • Income tax expense amounted to 3.0% of revenue in FY2025, down 2.0 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -51.1% toward the trailing-twelve-month pace of -24.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$492K-45.5% QoQ
Last fiscal yearJun 2025
$3.11M-39.9% YoY
LTMMar 2026
$2.5M-24.4% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-51.1%——
1 year-39.9%——
3-year CAGR-17.5%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
3.11M USD
Year-over-year change
-39.9%
4-year CAGR
-6.1%

Income Tax Expense vs competitors

How FONR compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -24.4% is the 4th highest of 5, against a peer median of +44.7%.
  • Income tax expense amounts to 2.4% of revenue for FONR, versus a peer median of 0.7%.
FONR Competitors
Income Tax Expense for FONR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FONRFONAR CorporationLTM Mar 2026$2.5M USD-24.4%-17.5%2.4%
LUNGPulmonx CorporationLTM Mar 2026$640K USD+42.5%+21.0%0.7%
APYXApyx Medical CorporationLTM Mar 2026$364K USD+46.8%-9.7%0.7%
IFRXInflaRx N.V.LTM Mar 2026€12.28K EUR+135.4%—41.9%
ARTVArtiva Biotherapeutics, Inc.LTM Mar 2026$0 USD———
HYPRHyperfine, Inc.LTM Mar 2026$0 USD——0.0%
VANIVivani Medical, Inc.LTM Mar 2026$0 USD———
RCELAVITA Medical, Inc.LTM Mar 2026-$9K USD-128.1%-32.6%0.0%
Peer median (excluding FONR) —+44.7%-9.7%0.7%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue89.93M97.59M98.65M102.88M104.35M
Cost of Revenue46.46M50.58M52.9M57.74M61.44M
Gross Profit43.47M47.01M45.75M45.14M42.91M
Gross Margin48.3%48.2%46.4%43.9%41.1%
Research & Development1.64M1.49M1.57M1.74M1.58M
Selling, General & Admin0029.39M029.73M
Operating Expenses26.38M25.01M30.96M28.6M31.31M
Depreciation & Amortization4.08M4.54M8.8M4.6M4.7M
EBITDA22M27.65M24.61M23.94M18.5M
EBITDA Margin24.5%28.3%25.0%23.3%17.7%
Operating Income17.1M22.01M14.79M16.54M11.6M
Operating Margin19.0%22.6%15.0%16.1%11.1%
Interest Income00002.17M
Interest Expense248.67K346.55K50.13K77K25.61K
Other Income / Expenses567.72K761.69K969.33K2.73M2.18M
Income Before Tax17.67M22.77M15.76M19.27M13.78M
Pre-Tax Margin19.6%23.3%16.0%18.7%13.2%
Income Tax Expense3.99M5.53M3.63M5.17M3.11M
Net Income10.21M12.44M9.38M10.57M8.33M
Net Margin11.4%12.7%9.5%10.3%8.0%
EPS (Basic)1.471.781.351.561.26
EPS (Diluted)1.451.751.321.531.23
Weighted Avg Shares6.61M6.55M6.65M6.35M6.32M
Weighted Avg Shares (Diluted)6.74M6.68M6.77M6.48M6.55M

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.